• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宿主 Cxcr2 依赖性调控胰腺癌生长、血管生成和转移。

Host Cxcr2-Dependent Regulation of Pancreatic Cancer Growth, Angiogenesis, and Metastasis.

机构信息

Department of Pathology and Microbiology, Nebraska Medical Center, Omaha, Nebraska.

Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska.

出版信息

Am J Pathol. 2021 Apr;191(4):759-771. doi: 10.1016/j.ajpath.2021.01.002. Epub 2021 Jan 14.

DOI:10.1016/j.ajpath.2021.01.002
PMID:33453178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8027924/
Abstract

Pancreatic ductal adenocarcinoma (PDAC) manifests aggressive tumor growth and early metastasis. Crucial steps in tumor growth and metastasis are survival, angiogenesis, invasion, and immunosuppression. Our prior research showed that chemokine CXC- receptor-2 (CXCR2) is expressed on endothelial cells, innate immune cells, and fibroblasts, and regulates angiogenesis and immune responses. Here, we examined whether tumor angiogenesis, growth, and metastasis of CXCR2 ligands expressing PDAC cells are regulated in vivo by a host CXCR2-dependent mechanism. C57BL6 Cxcr2 mice were generated following crosses between Cxcr2 female and Cxcr2 male. Cxcr2 ligands expressing Kirsten rat sarcoma (KRAS-PDAC) cells were orthotopically implanted in the pancreas of wild-type or Cxcr2 C57BL6 mice. No significant difference in PDAC tumor growth was observed. Host Cxcr2 loss led to an inhibition in microvessel density in PDAC tumors. Interestingly, an enhanced spontaneous and experimental liver metastasis was observed in Cxcr2 mice compared with wild-type mice. Increased metastasis in Cxcr2 mice was associated with an increase in extramedullary hematopoiesis and expansion of neutrophils and immature myeloid precursor cells in the spleen of tumor-bearing mice. These data suggest a dynamic role of host CXCR2 axis in regulating tumor immune suppression, tumor growth, and metastasis.

摘要

胰腺导管腺癌 (PDAC) 表现出侵袭性肿瘤生长和早期转移。肿瘤生长和转移的关键步骤包括存活、血管生成、侵袭和免疫抑制。我们之前的研究表明,趋化因子 CXC-受体-2 (CXCR2) 在内皮细胞、固有免疫细胞和成纤维细胞上表达,并调节血管生成和免疫反应。在这里,我们研究了表达 CXCR2 配体的 PDAC 细胞的肿瘤血管生成、生长和转移是否受宿主 CXCR2 依赖性机制的调节。通过雌性和雄性 Cxcr2 之间的杂交产生 C57BL6 Cxcr2 小鼠。将表达 Kirsten 大鼠肉瘤 (KRAS-PDAC) 细胞的 CXCR2 配体原位植入野生型或 Cxcr2 C57BL6 小鼠的胰腺中。未观察到 PDAC 肿瘤生长的显著差异。宿主 Cxcr2 缺失导致 PDAC 肿瘤中的微血管密度抑制。有趣的是,与野生型小鼠相比,Cxcr2 小鼠中自发和实验性肝转移明显增加。Cxcr2 小鼠中的转移增加与骨髓外造血增加以及肿瘤携带小鼠脾脏中中性粒细胞和未成熟髓样前体细胞的扩张有关。这些数据表明宿主 CXCR2 轴在调节肿瘤免疫抑制、肿瘤生长和转移方面具有动态作用。

相似文献

1
Host Cxcr2-Dependent Regulation of Pancreatic Cancer Growth, Angiogenesis, and Metastasis.宿主 Cxcr2 依赖性调控胰腺癌生长、血管生成和转移。
Am J Pathol. 2021 Apr;191(4):759-771. doi: 10.1016/j.ajpath.2021.01.002. Epub 2021 Jan 14.
2
Host Cxcr2-dependent regulation of mammary tumor growth and metastasis.宿主Cxcr2依赖性对乳腺肿瘤生长和转移的调控。
Clin Exp Metastasis. 2015 Jan;32(1):65-72. doi: 10.1007/s10585-014-9691-0. Epub 2014 Dec 16.
3
CXCR2 signaling promotes secretory cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.CXCR2 信号促进胰腺导管腺癌中的分泌型癌症相关成纤维细胞。
FASEB J. 2020 Jul;34(7):9405-9418. doi: 10.1096/fj.201902990R. Epub 2020 May 26.
4
Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma.抑制 Cxcr2 破坏肿瘤-基质相互作用,并改善胰腺导管腺癌小鼠模型的生存。
J Clin Invest. 2011 Oct;121(10):4106-17. doi: 10.1172/JCI42754. Epub 2011 Sep 19.
5
Duffy antigen receptor for chemokines (DARC) expressing in cancer cells inhibits tumor progression by suppressing CXCR2 signaling in human pancreatic ductal adenocarcinoma.癌细胞中表达的趋化因子达菲抗原受体(DARC)通过抑制人胰腺导管腺癌中的CXCR2信号传导来抑制肿瘤进展。
Cytokine. 2017 Jul;95:12-21. doi: 10.1016/j.cyto.2017.02.007. Epub 2017 Feb 20.
6
CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer.CXC趋化因子/CXCR2生物学轴在体外和体内均促进胰腺癌血管生成。
Int J Cancer. 2009 Sep 1;125(5):1027-37. doi: 10.1002/ijc.24383.
7
Host CXCR2-dependent regulation of melanoma growth, angiogenesis, and experimental lung metastasis.宿主CXCR2依赖性对黑色素瘤生长、血管生成及实验性肺转移的调控
Cancer Res. 2009 Jan 15;69(2):411-5. doi: 10.1158/0008-5472.CAN-08-3378.
8
CXCR2-Dependent Accumulation of Tumor-Associated Neutrophils Regulates T-cell Immunity in Pancreatic Ductal Adenocarcinoma.肿瘤相关中性粒细胞的CXCR2依赖性积累调节胰腺导管腺癌中的T细胞免疫。
Cancer Immunol Res. 2016 Nov;4(11):968-982. doi: 10.1158/2326-6066.CIR-16-0188. Epub 2016 Oct 13.
9
Targeting both tumour-associated CXCR2 neutrophils and CCR2 macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma.靶向肿瘤相关 CXCR2 中性粒细胞和 CCR2 巨噬细胞可破坏髓系细胞募集并改善胰腺导管腺癌的化疗反应。
Gut. 2018 Jun;67(6):1112-1123. doi: 10.1136/gutjnl-2017-313738. Epub 2017 Dec 1.
10
CXCR2 signaling regulates KRAS(G¹²D)-induced autocrine growth of pancreatic cancer.CXCR2信号传导调节KRAS(G¹²D)诱导的胰腺癌自分泌生长。
Oncotarget. 2016 Feb 9;7(6):7280-96. doi: 10.18632/oncotarget.6906.

引用本文的文献

1
Immunosuppressive tumor microenvironment in pancreatic cancer: mechanisms and therapeutic targets.胰腺癌中的免疫抑制性肿瘤微环境:机制与治疗靶点
Front Immunol. 2025 May 15;16:1582305. doi: 10.3389/fimmu.2025.1582305. eCollection 2025.
2
Depletion of tumor-derived CXCL5 improves T cell infiltration and anti-PD-1 therapy response in an obese model of pancreatic cancer.在肥胖型胰腺癌模型中,肿瘤源性CXCL5的消耗可改善T细胞浸润和抗PD-1治疗反应。
J Immunother Cancer. 2025 Mar 22;13(3):e010057. doi: 10.1136/jitc-2024-010057.
3
MYBBP1A‑mediated IGFBP4 promoter methylation promotes epithelial‑mesenchymal transition and metastasis through activation of NOTCH pathway in liver cancer.MYBBP1A 介导的 IGFBP4 启动子甲基化通过激活 NOTCH 通路促进肝癌中的上皮-间充质转化和转移。
Int J Oncol. 2025 Jan;66(1). doi: 10.3892/ijo.2024.5710. Epub 2024 Nov 29.
4
The Laws of Attraction: Chemokines as Critical Mediators in Cancer Progression and Immunotherapy Response in Bladder Cancer.吸引力法则:趋化因子作为膀胱癌进展和免疫治疗反应的关键介质
Cancers (Basel). 2024 Sep 27;16(19):3303. doi: 10.3390/cancers16193303.
5
Non-homogenous intratumor ionizing radiation doses synergize with PD1 and CXCR2 blockade.非同质肿瘤内放射剂量与 PD1 和 CXCR2 阻断协同作用。
Nat Commun. 2024 Oct 14;15(1):8845. doi: 10.1038/s41467-024-53015-9.
6
Macrophage migration inhibitory factor as a therapeutic target in neuro-oncology: A review.巨噬细胞迁移抑制因子作为神经肿瘤学的治疗靶点:综述
Neurooncol Adv. 2024 Aug 10;6(1):vdae142. doi: 10.1093/noajnl/vdae142. eCollection 2024 Jan-Dec.
7
Infiltration of CD3+ and CD8+ lymphocytes in association with inflammation and survival in pancreatic cancer.CD3+ 和 CD8+ 淋巴细胞浸润与胰腺癌中的炎症和生存相关。
PLoS One. 2024 Feb 12;19(2):e0297325. doi: 10.1371/journal.pone.0297325. eCollection 2024.
8
The Involvement of Cysteine-X-Cysteine Motif Chemokine Receptors in Skin Homeostasis and the Pathogenesis of Allergic Contact Dermatitis and Psoriasis.半胱氨酸-X-半胱氨酸基趋化因子受体在皮肤稳态和过敏性接触性皮炎及银屑病发病机制中的作用。
Int J Mol Sci. 2024 Jan 13;25(2):1005. doi: 10.3390/ijms25021005.
9
Gastric tubular adenocarcinoma with diffuse neutrophils infiltrating: characteristics and probable treatment strategy.弥漫中性粒细胞浸润的胃管状腺癌:特征及可能的治疗策略。
Gastric Cancer. 2024 Jan;27(1):86-101. doi: 10.1007/s10120-023-01446-6. Epub 2023 Nov 29.
10
Small Molecule Targeting Immune Cells: A Novel Approach for Cancer Treatment.靶向免疫细胞的小分子:一种癌症治疗的新方法。
Biomedicines. 2023 Sep 24;11(10):2621. doi: 10.3390/biomedicines11102621.

本文引用的文献

1
Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects.肿瘤微环境中的调节性 T 细胞:新机制、潜在治疗策略和未来前景。
Mol Cancer. 2020 Jul 17;19(1):116. doi: 10.1186/s12943-020-01234-1.
2
CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity.肿瘤产生的 CXCR1 和 CXCR2 趋化因子受体激动剂诱导中性粒细胞细胞外陷阱,干扰免疫细胞毒性。
Immunity. 2020 May 19;52(5):856-871.e8. doi: 10.1016/j.immuni.2020.03.001. Epub 2020 Apr 13.
3
Regulatory T Cells and Human Disease.调节性 T 细胞与人类疾病。
Annu Rev Immunol. 2020 Apr 26;38:541-566. doi: 10.1146/annurev-immunol-042718-041717. Epub 2020 Feb 4.
4
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
5
IL-17-CXC Chemokine Receptor 2 Axis Facilitates Breast Cancer Progression by Up-Regulating Neutrophil Recruitment.IL-17-CXC 趋化因子受体 2 轴通过上调中性粒细胞募集促进乳腺癌进展。
Am J Pathol. 2020 Jan;190(1):222-233. doi: 10.1016/j.ajpath.2019.09.016. Epub 2019 Oct 22.
6
Roles of Regulatory T Cells in Tissue Pathophysiology and Metabolism.调节性 T 细胞在组织病理生理学和代谢中的作用。
Cell Metab. 2020 Jan 7;31(1):18-25. doi: 10.1016/j.cmet.2019.09.010. Epub 2019 Oct 10.
7
CXCR2 expression on granulocyte and macrophage progenitors under tumor conditions contributes to mo-MDSC generation via SAP18/ERK/STAT3.肿瘤微环境中粒细胞-巨噬细胞祖细胞上的 CXCR2 表达通过 SAP18/ERK/STAT3 促进 mo-MDSC 的产生。
Cell Death Dis. 2019 Aug 8;10(8):598. doi: 10.1038/s41419-019-1837-1.
8
Expression of costimulatory and inhibitory receptors in FoxP3 regulatory T cells within the tumor microenvironment: Implications for combination immunotherapy approaches.肿瘤微环境中 FoxP3 调节性 T 细胞中共刺激和共抑制受体的表达:对联合免疫治疗方法的影响。
Adv Cancer Res. 2019;144:193-261. doi: 10.1016/bs.acr.2019.05.001. Epub 2019 Jun 6.
9
Tumor-Associated Neutrophils in Cancer: Going Pro.癌症中的肿瘤相关中性粒细胞:走向“专业”化。
Cancers (Basel). 2019 Apr 19;11(4):564. doi: 10.3390/cancers11040564.
10
CXCR2: A Novel Mediator of Mammary Tumor Bone Metastasis.CXCR2:乳腺癌骨转移的新型介质。
Int J Mol Sci. 2019 Mar 12;20(5):1237. doi: 10.3390/ijms20051237.